Pseudohypoparathyroidism Type 1a, pseudopseudohypoparathyroidism, and albright hereditary osteodystrophy

Hypoparathyroidism

Volumn , Issue , 2015, Pages 355-362

  Weinstein, Lee S ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

G protein; Genomic imprinting; Obesity; Osteodystrophy; Parathyroid hormone

Indexed keywords

EID: 84948754245     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-88-470-5376-2_33     Document Type: Chapter

References (39)

1. Weinstein LS (2008) Guanine nucleotide-binding protein G s α (GNAS1 ): fibrous dysplasia, McCune- Albright syndrome, Albright hereditary osteodystrophy, and pseudohypoparathyroidism. In: Epstein CJ, Erickson RP, Wynshaw-Boris A (eds) Inborn errors of development: the molecular basis of clinical disorders of morphogenesis, 2nd edn. Oxford University Press, New York, pp 1277-1288
2. de Sanctis L, Vai S, Andreo MR et al (2004) Brachydactyly in 14 genetically characterized pseudohypoparathyroidism type Ia patients. J Clin Endocrinol Metab 89:1650-1655
3. Roberts TT, Khasnavis S, Papaliodis DN et al (2013) Spinal cord compression in pseudohypoparathyroidism. Spine J 13:e15-e19
4. Joseph AW, Shoemaker AH, Germain-Lee EL (2011) Increased prevalence of carpal tunnel syndrome in Albright hereditary osteodystrophy. J Clin Endocrinol Metab 96:2065-2073
5. Mouallem M, Shaharabany M, Weintrob N et al (2008) Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsα. Clin Endocrinol (Oxf) 68:233-239
6. Kaplan FS, Shore EI (2000) Progressive osseous heteroplasia. J Bone Miner Res 15:2084-2094
7. Long DN, Levine MA, Germain-Lee EL (2010) Bone mineral density in pseudohypoparathyroidism type 1a. J Clin Endocrinol Metab 95:4465-4475
8. Namnoum AB, Merriam GR, Moses AM et al (1998) Reproductive dysfunction in women with Albright’s hereditary osteodystrophy. J Clin Endocrinol Metab 83:824-829
9. Germain-Lee EL, Groman J, Crane JL et al (2003) Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab 88: 4059-4069
10. Long DN, McGuire S, Levine MA et al (2007) Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Gα s in the development of human obesity. J Clin Endocrinol Metab 92:1073-1079
11. Muniyappa R, Warren MA, Zhao X et al (2013) Reduced insulin sensitivity in adults with pseudohypoparathyroidism type 1a. J Clin Endocrinol Metab 98:E1796-E1801
12. Chen M, Wang J, Dickerson KE et al (2009) Central nervous system imprinting of the G protein G s α and its role in metabolic regulation. Cell Metab 9:548-555
13. Weinstein LS, Xie T, Zhang QH et al (2007) Studies of the regulation and function of the G s α gene Gnas using gene targeting technology. Pharmacol Ther 115:271-291
14. Mariot V, Maupetit-Mehouas S, Sinding C et al (2008) A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance. J Clin Endocrinol Metab 93:661-665
15. Mantovani G, de Sanctis L, Barbieri AM et al (2010) Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab 95:651-658
16. Zazo C, Thiele S, Martin C et al (2011) G s α activity is reduced in erythrocyte membranes of patients with pseudohypoparathyroidism due to epigenetic alterations at the GNAS locus. J Bone Miner Res 26:1864-1870
17. Yu S, Yu D, Hainline BE et al (1995) A deletion hotspot in exon 7 of the G s α gene (GNAS1 ) in patients with Albright hereditary osteodystrophy. Hum Mol Genet 4:2001-2002
18. Thiele S, Werner R, Ahrens W et al (2007) A disruptive mutation in exon 3 of the GNAS gene with Albright hereditary osteodystrophy, normocalcemic pseudohypoparathyroidism, and selective long transcript variant Gsα-L deficiency. J Clin Endocrinol Metab 92:1764-1768
19. Shore EM, Ahn J, Jan de Beur S et al (2002) Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med 346: 99-106
20. Yu S, Yu D, Lee E et al (1998) Variable and tissuespecific hormone resistance in heterotrimeric G s protein α-subunit G s α knockout mice is due to tissuespecific imprinting of the G s α gene. Proc Natl Acad Sci U S A 95:8715-8720
21. Turan S, Fernandez-Rebollo E, Aydin C et al (2014) Postnatal establishment of allelic Gα s silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous Gα s disruption. J Bone Miner Res 29:749-760
22. Weinstein LS (2001) The stimulatory G protein α- subunit gene: mutations and imprinting lead to complex phenotypes. J Clin Endocrinol Metab 86:4622-4626
23. Stone MD, Hosking DJ, Garcia-Himmelstine C et al (1993) The renal response to exogenous parathyroid hormone in treated pseudohypoparathyroidism. Bone 14:727-735
24. Xie T, Chen M, Gavrilova O et al (2008) Severe obesity and insulin resistance due to deletion of the maternal G s α allele is reversed by paternal deletion of the G s α imprint control region. Endocrinology 149: 2443-2450
25. Chen M, Berger A, Kablan A et al (2012) G s α deficiency in the paraventricular nucleus of the hypothalamus partially contributes to obesity associated with G s α mutations. Endocrinology 153:4256-4265
26. Carel JC, Le Stunff C, Condamine L et al (1999) Resistance to the lipolytic action of epinephrine: a new feature of protein G s deficiency. J Clin Endocrinol Metab 84:4127-4131
27. Dekelbab BH, Aughton DJ, Levine MA (2009) Pseudohypoparathyroidism type 1A and morbid obesity in infancy. Endocr Pract 15:249-253
28. Shoemaker AH, Lomenick JP, Saville BR et al (2013) Energy expenditure in obese children with pseudohypoparathyroidism type 1a. Int J Obes (Lond) 37: 1147-1153
29. Sakamoto A, Chen M, Kobayashi T et al (2005) Chondrocyte-specific knockout of the G protein G s α leads to epiphyseal and growth plate abnormalities and ectopic chondrocyte formation. J Bone Miner Res 20:663-671
30. Bastepe M, Weinstein LS, Ogata N et al (2004) Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo. Proc Natl Acad Sci U S A 101:14794-14799
31. Huso DL, Edie S, Levine MA et al (2011) Heterotopic ossifications in a mouse model of Albright hereditary osteodystrophy. PLoS One 6:e21755
32. Regard JB, Malhotra D, Gvozdenovic-Jeremic J et al (2013) Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification. Nat Med 19:1505-1512
33. Linglart A, Fryssira H, Hiort O et al (2012) PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance. J Clin Endocrinol Metab 97: E2328-E2338
34. Linglart A, Menguy C, Couvineau A et al (2011) Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N Engl J Med 364:2218-2226
35. Thiele S, de Sanctis L, Werner R et al (2011) Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively G s α-receptor interaction. Hum Mutat 32:653-660
36. Neary NM, El-Maouche D, Hopkins R et al (2012) Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B. J Clin Endocrinol Metab 97:3025-3030
37. Mantovani G, Ferrante E, Giavoli C et al (2010) Recombinant human GH replacement therapy in children with pseudohypoparathyroidism type Ia: first study on the effect on growth. J Clin Endocrinol Metab 95:5011-5017
38. Lietman SA, Goldfarb J, Desai N et al (2008) Preimplantation genetic diagnosis for severe Albright hereditary osteodystrophy. J Clin Endocrinol Metab 93:901-904
39. Weinstein LS, Collins MT, Spiegel AM (2013) G s α, pseudohypoparathyroidism, fibrous dysplasia, and McCune-Albright syndrome. In: Thakkar RV, Whyte MP, Eisman JA, Igarashi T (eds) (2013) Genetics of bone biology and skeletal disease. Academic, London, pp 425-440